(Q41582396)

4 October 2017

1 reference

title

Recognition and management of systemic lupus erythematosus (English)

1 reference

4 October 2017

Schroeder JO

1

1 reference

4 October 2017

Euler HH

series ordinal

2

1 reference

4 October 2017

language of work or name

1 reference

1 September 1997

1 reference

4 October 2017

1 reference

4 October 2017

54

1 reference

4 October 2017

3

1 reference

4 October 2017

422-434

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199754030-00005

4 October 2017

0 references

cites work

Cyclosporine treatment of lupus membranous nephropathy

1 reference

12 December 2020

Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center

1 reference

12 December 2020

What is lupus? What is not lupus?

1 reference

12 December 2020

Plasmapheresis in SLE

1 reference

12 December 2020

Acute renal failure associated with immunoglobulin therapy

1 reference

12 December 2020

Incidence of systemic lupus erythematosus. Race and gender differences

1 reference

12 December 2020

Hypertension increases the risk of renal deterioration in systemic lupus erythematosus

1 reference

12 December 2020

A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.

1 reference

12 December 2020

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

1 reference

12 December 2020

Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus

1 reference

12 December 2020

Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis

1 reference

12 December 2020

Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine

1 reference

12 December 2020

Cyclophosphamide: ovarian and other toxicities

1 reference

12 December 2020

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

1 reference

12 December 2020

Retinoid teratogenesis: toxicokinetics and structure-specificity

1 reference

12 December 2020

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

12 December 2020

A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Azathioprine in the treatment of systemic lupus erythematosus. A controlled study

1 reference

12 December 2020

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

1 reference

12 December 2020

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

12 December 2020

Prevention of relapses in systemic lupus erythematosus

1 reference

12 December 2020

Effect of dapsone on haemoglobin concentration in patients with leprosy.

1 reference

12 December 2020

Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study

1 reference

12 December 2020

Methotrexate in systemic lupus erythematosus

1 reference

12 December 2020

Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

1 reference

12 December 2020

Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death

1 reference

12 December 2020

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

1 reference

12 December 2020

Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes

1 reference

12 December 2020

Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases

1 reference

12 December 2020

Hydroxychloroquine, dosage parameters and retinopathy

1 reference

12 December 2020

Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate

1 reference

12 December 2020

A revised estimate of twin concordance in systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

1 reference

12 December 2020

Lupus nephritis: lessons from the path lab.

1 reference

12 December 2020

Systemic lupus erythematosus

1 reference

12 December 2020

Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus

1 reference

12 December 2020

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

12 December 2020

Autoantibodies in the diagnosis of systemic rheumatic diseases

1 reference

12 December 2020

High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study

1 reference

12 December 2020

Treatment. Corticosteroids and anti-inflammatory drugs

1 reference

12 December 2020

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

1 reference

12 December 2020

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail

1 reference

12 December 2020

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

12 December 2020

Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.

1 reference

12 December 2020

Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease

1 reference

12 December 2020

Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody

1 reference

12 December 2020

Treatment of lupus interstitial lung disease with intravenous cyclophosphamide

1 reference

12 December 2020

Successful use of nitrogen mustard for cyclophosphamide resistant diffuse proliferative lupus glomerulonephritis: report of 2 cases

1 reference

12 December 2020

Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies

1 reference

12 December 2020

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma

1 reference

12 December 2020

Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity

1 reference

12 December 2020

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

12 December 2020

Hydroxychloroquine toxicity despite normal dose therapy

1 reference

12 December 2020

The ocular safety of hydroxychloroquine.

1 reference

12 December 2020

Danazol for the Treatment of Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus

1 reference

12 December 2020

Treatment of cutaneous lesions in patients with lupus erythematosus

1 reference

12 December 2020

Cancer in patients treated with immunosuppressive drugs

1 reference

12 December 2020

Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus?

1 reference

12 December 2020

Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus.

1 reference

12 December 2020

Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy

1 reference

12 December 2020

The oncogenicity of chlorambucil in rheumatoid arthritis

1 reference

12 December 2020

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

12 December 2020

Randomised trial of plasma exchange in mild systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

1 reference

12 December 2020

Ocular safety of hydroxychloroquine sulfate (Plaquenil).

1 reference

12 December 2020

NIH conference. Systemic lupus erythematosus

1 reference

12 December 2020

Michael Mason Prize Essay 1995. Complement, immune complexes and systemic lupus erythematosus

1 reference

12 December 2020

Acute renal failure after intravenous immunoglobulin therapy

1 reference

12 December 2020

Antimalarial agents and lupus.

1 reference

12 December 2020

Lupus retinopathy. Patterns, associations, and prognosis

1 reference

12 December 2020

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

12 December 2020

Long-term i.v. Ig treatment in systemic lupus erythematosus.

1 reference

12 December 2020

Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study

1 reference

12 December 2020

The changing face of therapy for rheumatoid arthritis

1 reference

12 December 2020

Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus

1 reference

12 December 2020

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

1 reference

12 December 2020

Systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Immunology of the antiphospholipid antibody syndrome

1 reference

12 December 2020

The favourable effect of cyclophosphamide pulse therapy in the treatment of massive pulmonary haemorrhage in systemic lupus erythematosus

1 reference

12 December 2020

Monthly cyclophosphamide in lupus pneumonitis and myositis

1 reference

12 December 2020

Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia

1 reference

12 December 2020

Effects of immunosuppressive drugs during pregnancy

1 reference

12 December 2020

High-dose intravenous IgG treatment and renal function

1 reference

12 December 2020

Revisiting autoantibody profiles in systemic lupus erythematosus

1 reference

12 December 2020

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

1 reference

12 December 2020

Lipid profiles in patients with systemic lupus erythematosus

1 reference

12 December 2020

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

1 reference

12 December 2020

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

12 December 2020

An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus

1 reference

12 December 2020

NSAID usage patterns by rheumatologists in the treatment of SLE

1 reference

12 December 2020

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

12 December 2020

Acute renal failure resulting from intravenous immunoglobulin therapy

1 reference

12 December 2020

Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide

1 reference

12 December 2020

Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation

1 reference

12 December 2020

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

1 reference

12 December 2020

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients

1 reference

12 December 2020

Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity

1 reference

12 December 2020

The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition

1 reference

12 December 2020

Ibuprofen and aseptic meningitis

1 reference

12 December 2020

Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study

1 reference

12 December 2020

Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity

1 reference

12 December 2020

Systemic lupus erythematosus and pregnancy

1 reference

12 December 2020

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

12 December 2020

Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial

1 reference

12 December 2020

Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus.

1 reference

12 December 2020

Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases

1 reference

12 December 2020

Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus

1 reference

12 December 2020

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

12 December 2020

10.2165/00003495-199754030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

4 October 2017

0 references

1 reference